Where to buy sales lead generation services for insurtech in the UK

Cormac Repman
4 days ago
5 min read

The Insurtech Buyer's Guide to Lead Generation in the UK

If you're building an insurtech company in the UK, you've probably heard the pitch a hundred times: "We have the perfect leads for you." Most of them are worthless. I've seen insurtech founders spend £15,000 on lead lists that generated exactly zero qualified conversations. The problem isn't that lead generation services don't work. It's that most of them don't understand the insurtech sales cycle or the UK regulatory landscape that makes B2B insurance tech sales different.

This guide cuts through the noise and tells you what actually works when you're buying lead generation services for an insurtech business.

Why Generic Lead Gen Fails in Insurtech

Insurtech isn't like other SaaS. Your buyer isn't a CTO responding to product-market fit signals. They're typically a Chief Risk Officer, Head of Compliance, or Operations Director at an established insurance firm who's evaluating your solution against entrenched systems and regulatory risk.

When you buy leads from a generic B2B provider, you get lists built on job title matching and company size. That works for HR software. For insurtech, it's useless. A Head of Compliance at a mid-market insurer might be interested in your API, but the lead list you bought pulls everyone with "Compliance" in their title across all industries. You're wasting time on finance compliance officers and healthcare compliance managers.

Conversion rates on generic B2B lead lists sit around 2-4%. For insurtech outreach, we've seen them drop to 0.5% or lower. That's not because your product is bad. It's because the list was built wrong.

The Four Main Types of Lead Gen Services Available

1. List Brokers and Database Providers

These are companies like ZoomInfo, Apollo, and Hunter. They scrape public data and sell access to contact databases. Cost is typically £300-2000/month for basic access.

Pros: Cheap, quick, and you can instantly download thousands of prospects.

Cons: Data quality varies wildly. Most UK insurtech founders tell us the contact info is 40-60% outdated. You'll spend more time verifying phone numbers than actually calling.

2. Managed Lead Gen Agencies

Companies that build and manage entire campaigns for you. They handle list creation, outreach sequencing, and often light qualification. Cost ranges from £5,000 to £50,000/month depending on scope.

Pros: Hands-off. They own the entire process.

Cons: You're paying for their overhead. Long sales cycles mean you won't see real results for 90-120 days. Most charge by the campaign, not by qualified conversations. If a campaign underperforms, you're still paying full price.

3. Cold Calling Teams (Offshore and UK-Based)

These teams make calls on your behalf. Cost typically runs £2,000-8,000/month per team member, or £15,000-40,000/month for a full team.

Pros: Real human conversations at scale. Direct feedback on why prospects aren't interested.

Cons: Quality varies dramatically. An offshore team with no insurance industry knowledge will fumble conversations. UK-based teams are more expensive but get better results. You need to provide call scripts and train the team on your product.

4. Pay-Per-Meeting Models

This is what we do at Nurturance. You only pay when a qualified prospect books a meeting with your team. No upfront campaign fees, no retainers, no guessing on ROI. Pricing typically runs £200-500 per qualified meeting depending on industry complexity and geography.

Pros: Aligned incentives. The vendor only gets paid if they produce real conversations. You know the cost per meeting before you start.

Cons: Limited availability. Not many firms run this model profitably. Requires extremely targeted outreach so the meetings actually convert.

What to Look For When Evaluating Providers

1. Insurance Industry Experience

Ask direct questions. Do they understand FCA regulations? Have they worked with insurance carriers before, or just insurtech startups? Do they know the difference between a managing general agent and an insurance distribution directive requirement? If they're blank on these, they'll waste your time.

2. Real Metrics, Not Vanity Stats

Anyone can claim "high connect rates." Push for specific numbers on your segment. What's the actual conversation rate for UK insurance firms with 500-2000 employees? What percentage of conversations convert to meetings? Most providers won't have this data because they don't track it by vertical. That's a red flag.

3. Targeting Specificity

Generic lists are cheap because they're generic. If a provider sends you 50,000 contacts and says "pick the ones you want," they haven't done work. Real targeting means they've identified specific decision-makers at specific firms where your solution solves a known problem. You should get maybe 500-2000 high-quality targets, not 50,000 guesses.

4. Alignment on Outcomes

The best providers have skin in the game. Fixed retainers create perverse incentives: they get paid whether you book meetings or not. Pay-per-outcome models (per qualified conversation, per booked meeting, per deal) mean the provider succeeds when you succeed.

Common Mistakes When Buying Lead Gen

Mistake 1: Assuming more leads = better results. A list of 10,000 random contacts is worse than 100 highly targeted ones. Spend time qualifying the targeting before buying volume.

Mistake 2: Not allocating internal resources. You need someone on your team to vet prospects, update CRM data, and handle follow-ups. Lead generation isn't a black box. If you buy leads and ignore them for two weeks, conversion drops 60%.

Mistake 3: Expecting immediate results. Even the best lead gen takes 30-60 days to show real signal. Insurance buyers move slowly. If a provider promises results in two weeks, they're overselling.

Mistake 4: Buying lists without a sales process. You can have perfect leads, but if your sales team isn't trained to handle insurance industry objections, you'll still fail. The lead is only part of the equation.

How to Calculate ROI Before You Buy

Work backwards from your deal value. If your average deal is worth £50,000 and your close rate on qualified meetings is 15%, then each qualified meeting is worth £7,500 in expected revenue.

If a provider charges £300 per qualified meeting, your cost per deal is £2,000 (assuming the same 15% close rate). That's a 25x return. Worth buying.

If they charge £500 per meeting, your cost per deal is £3,333. Still a 15x return. Still worth it.

If you're buying a £5,000 list of 1,000 contacts with no outcome guarantee, assume a 0.5% conversion to meeting (5 meetings). That's £1,000 per meeting before you even schedule a call. That's probably too expensive unless your deal value is north of £100,000.

The math matters. Run it before you commit budget.

Why Nurturance Is Different

We run real cold calling teams in the UK through the Glencoco marketplace. We don't sell you lists. We sell you booked meetings with decision-makers at insurance firms who actually need what you're building.

Here's how we work: we spend the first week researching your target market and identifying companies where your solution solves a specific compliance or operational problem. We call those companies. We have real conversations. When we find someone interested and willing to talk to you, we book the meeting. You only pay us then.

For insurtech companies in the UK, this beats generic lead lists by 8-10x. We've built outbound strategies for fintech and insurtech firms that generate 15-25 qualified meetings per month at predictable cost per meeting.

If you want to talk about your specific situation, schedule a call and we'll do a quick audit of your market and tell you exactly what a realistic pipeline looks like.